Skip to content
Buy This GLP
← Research
Safety

Do GLP-1 Drugs Cause a Cough? What the Evidence Shows

A large medical record study found a small increase in recorded cough diagnoses within six months. Reflux is one possible explanation.

Editorial profile: Neil SandersBuy This GLP Editorial Team4 min read
Six-month odds ratio vs matched controls1.0cough1.46any laryngeal symptom1.19voice and resonance1.19Small absolute differences across a very large population.

Whether a new cough belongs among possible GLP-1 side effects depends on more than when it started. A U.S. electronic health record study matched 617,296 adults with obesity who started one of these drugs to an equal number of adults with obesity who did not use one. Matching accounted for age, sex, race and ethnicity [1].

How much more common was a recorded cough?

By six months, 2.36% of people in the treatment group and 1.63% of controls had a cough diagnosis in their records. The difference was 0.73 percentage points (95% CI 0.68 to 0.79). The odds ratio was 1.46 (95% CI 1.42 to 1.50). These are diagnoses documented in medical records, and the study cannot show how many patients had a cough they never reported.

The broader group of voice box and airway symptoms also had higher odds at six months (OR 1.19, 95% CI 1.16 to 1.21). The study’s drug-by-drug comparisons used this broader outcome, so they cannot tell us which medication is most likely to be associated with cough.

Could reflux explain the cough?

The pooled trial evidence on reflux suggests about four additional cases of gastroesophageal reflux disease per 1,000 people treated versus placebo (95% CI two to seven). The pooled risk ratio was 2.19 (95% CI 1.48 to 3.25)[2]. The trials measured reflux disease as a separate outcome.

In the medical record study, people with a reflux diagnosis had higher odds of a voice box or airway symptom whether or not they used a GLP-1 drug [1]. That pattern leaves reflux as a possible explanation, but it does not show that a medication triggered reflux and then cough.

What if a cough persists?

Tell your prescriber when the cough started and if you also noticed hoarseness or reflux symptoms. A clinician can consider the timing alongside other possible causes.

Frequently asked

Do GLP-1 drugs cause a cough?
One matched study found a recorded cough within six months in 2.36% of people who started a GLP-1 or dual GIP/GLP-1 drug and 1.63% of nonusers. The study found an association and could not determine the cause.
Is a cough after starting a GLP-1 likely to be reflux?
Reflux is one possible explanation. Randomized trial evidence suggests about four additional reflux disease diagnoses per 1,000 people treated versus placebo. Those data do not show whether reflux explains a cough after starting treatment.

Sources

  1. [1] Shah P, Kayekjian D, Nguyen SA, Meenan K, O'Rourke AK (2026). Association of Glucagon-Like Peptide-1 Receptor Analogues and Laryngeal Symptoms in Obese Adults The Laryngoscope. PMID 42584027
  2. [2] Chiang CH, et al. (2025). Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis Gastroenterology. PMID 40499738

More in Safety